If successful, the vaccine could protect women against ovarian cancer, which only around half of women survive long-term at the moment.

The American Cancer Society estimates that over 19,000 women will be newly diagnosed with ovarian cancer in 2024. As one of the more prevalent cancers among females, the desire for preventive measures against ovarian cancer is as strong as ever.

Scientists at the University of Oxford have just received funding to create the world's first vaccine for ovarian cancer, a deadly disease that affects thousands of people each year. The vaccine, called OvarianVax,

A laboratory hoping to develop a vaccine for ovarian cancer has been awarded funding. Scientists at the University of Oxford are creating OvarianVax, a vaccine which they hope will teach the immune system to recognise and attack the earliest stages of ovarian cancer.

The world’s first ovarian cancer vaccine has been awarded research funding in the United Kingdom, marking the first step toward a groundbreaking preventive measure that scientists say could eliminate the disease entirely.

A first-ever ovarian cancer vaccine – currently being developed by the University of Oxford hopes to wipe off the deadly cancer – which kills thousands of women across the world yearly. According to scientists – the jab could be given to all women preventatively to eliminate the disease,